Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
Compass Therapeutics
Compass Therapeutics
Northwell Health
University of Illinois at Chicago
Institut Claudius Regaud
Montefiore Medical Center
Montefiore Medical Center
University Hospitals Coventry and Warwickshire NHS Trust
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Centre Antoine Lacassagne
Gustave Roussy, Cancer Campus, Grand Paris
Associacao de Investigacao de Cuidados de Suporte em Oncologia
Memorial Sloan Kettering Cancer Center